LB2 - Late Breaker - 2: gonorrhoea and M. genitalium

Moderator(s)

• CK

  Christine Khosropour, MPH, PhD

  Associate Professor
  University of Washington
  Seattle, Washington, United States
• YG

  Yonatan Grad, MD, PhD

  Associate Professor
  Harvard T.H. Chan School of Public Health
  Boston, Massachusetts, United States

Presentations:

• 14:30 – 14:45 CST

  Evolving antimicrobial resistance in Mycoplasma genitalium: an updated global systematic review and meta-analysis
  

  Primary Presenter: Teck-Phui Chua – University of Melbourne
• 14:45 – 15:00 CST

  Does screening for Neisseria gonorrhoeae and Chlamydia trachomatis affect the incidence of these infections in MSM taking HIV-PrEP? Results from a randomized, multicenter, controlled trial
  

  Primary Presenter: Thibaut Vanbaelen, MD – Institute Of Tropical Medicine, Antwerp, Belgium
• 15:00 – 15:15 CST

  High prevalence of STIs among men engaged in transactional sex and alcohol use in western Kenya: Important implications for STI intervention
  

  Primary Presenter: Sue Napierala, PhD, MPH – RTI International
• 15:15 – 15:30 CST

  Initial findings from increased gonorrhea culture surveillance in Massachusetts
  

  Primary Presenter: Heather R. Elder, PhD, MPH (she/her/hers) – Massachusetts Department of Public Health
• 15:30 – 15:45 CST

  Detection of two ceftriaxone non-susceptible Neisseria gonorrhoeae isolates in an HIV pre-exposure prophylaxis program in Vietnam
  

  Primary Presenter: Paul Adamson, MD MPH (he/him/his) – Division of Infectious Diseases, UCLA School of Medicine
• 15:45 – 16:00 CST

  Development of a Cas13a-based Point-of-Care Test for Neisseria gonorrhoeae Detection and Gyrase A Genotype Determination
  

  Primary Presenter: Lao-Tzu Allan-Blitz, MD, MPH (he/him/his) – Brigham and Women's Hospital